Abobotulinum toxin a (Dysport) and botulinum toxin type a (Botox) for purposeful induction of eyelid ptosis

Ophthalmic Plastic and Reconstructive Surgery

Volumn 26, Issue 6, 2010, Pages 489-491

  Reddy, Usha P ^a   Woodward, Julie A ^a  

^a DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BELL PALSY; CASE REPORT; CHEMODENERVATION; CORNEA DYSTROPHY; CORNEA EROSION; DERMATOLOGICAL PROCEDURES; EYELID RETRACTION; FEMALE; HUMAN; KERATOPLASTY; MALE; PRIORITY JOURNAL; PTOSIS;

ADULT; AGED; BELL PALSY; BLEPHAROPTOSIS; BOTULINUM TOXINS, TYPE A; CORNEAL DISEASES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OCULOMOTOR MUSCLES;

EID: 78650481158     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/IOP.0b013e3181d8e150     Document Type: Article

References (3)

1. Ellis MF, Daniell M. An evaluation of the safety and efficacy of botulinum toxin type A (Botox) when used to produce a protective ptosis. Clin Experiment Ophthalmol 2001;29:394-9. (Pubitemid 34036741)
2. Naik MN, Gangopadhyay N, Fernandes M, et al. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection. Eye 2008;22:1132-6.
3. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin A: A focus on cosmetic procedures. Am J Clin Dermatol 2005;6:141-50. (Pubitemid 40994257)